Donepezil in a narrow concentration range augments control and impaired by beta-amyloid peptide hippocampal LTP in NMDAR-independent manner

Cellular and Molecular Neurobiology

Volumn 32, Issue 2, 2012, Pages 219-226

  Kapai, Nadezhda A ^a   Bukanova, Julia V ^a   Solntseva, Elena I ^a   Skrebitsky, Vladimir G ^a  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

Amyloid peptide; Donepezil; Hippocampus; LTP; NMDA current

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; DONEPEZIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; SPIKE; TREATMENT DURATION;

ACTION POTENTIALS; AMYLOID BETA-PEPTIDES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; INDANS; ION CHANNEL GATING; LONG-TERM POTENTIATION; MALE; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; TETANUS;

RATTUS;

EID: 84864676984     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-011-9751-9     Document Type: Article

References (42)

1. Adlard PA, James SA, Bush AI, Masters CL (2009) Beta-amyloid as a molecular therapeutic target in Alzheimer's disease. Drugs Today (Barc) 45:293-304
2. Akaike A, Takada-Takatori Y, Kume T, Izumi Y (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of a4 and a7 receptors in neuroprotection. J Mol Neurosci 40:211-216
3. Arias E, Gallego-Sandin S, Villarroya M, Garcia AG, Lopez MG (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SHSY5Y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther 315:1346-1353
4. Chen QS, Wei WZ, Shimahara T, Xie CW (2002) Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem 77:354-371
5. 2+ and synaptic plasticity. Cell Calcium 24:3773-3785
6. Curras MC, Dingledine R (1992) Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4- isoxazolepropionate receptors. Mol Pharmacol 41:520-526
7. Debanne D, Poo M-M (2010) Spike-timing dependent plasticity beyond synapse-pre- and post-synaptic plasticity of intrinsic neuronal excitability. Front Syn Neurosci 2:21. doi:10.3389/fnsyn.2010.00021
8. Dewachter I, Filipkowski RK, Priller C, Rise L, Neyton J, Croes S, Terwel D, Gysemansf M, Devijver H, Borghgraef P, Godauxe E, Kaczmarek L, Hermsc J, Van Leuven F (2009) Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiol Aging 30:241-256
9. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution currentrecording from cells and cell-free membrane patches. Pflugers Arch 391:85-100
10. Kapai NA, Solntseva EI, Skrebitsky VG (2010) Donepezil eliminates suppressive effects of beta-amyloid peptide (1-42) on long-term potentiation in the hippocampus. Bull Exp Biol Med 149:33-36
11. Kato K, Hayako H, Ishihara Y, Marui S, Iwane M, Miyamoto M (1999) TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons. Neurosci Lett 260:5-8
12. Kenney JW, Gould TJ (2008) Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 38:101-121
13. Kimura M, Akasofu S, Ogura H, Sawada K (2005) Protective effect of donepezil against Abeta (1-40) neurotoxicity in rat septal neurons. Brain Res 1047:72-84
14. Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (2000) Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. Eur J Pharmacol 389:173-179
15. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Ab oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807
16. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352-357
17. Luo L, Chen W-H, Wang M, Zhu D-M, She J-Q, Ruan D-Y (2008) Modulation of long-term potentiation by individual subtypes of muscarinic acetylcholine receptor in the rat dentate gyrus. Hippocampus 18:989-995
18. Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44:5-21
19. Matthies H, Staak S, Krug M (1996) Fucose and fucosyllactose enhance in vitro hippocampal long-term potentiation. Brain Res 725:276-280
20. Meunier J, Ieni J, Maurice T (2006) The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptideinduced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol 149:998-1012
21. Molnár Z, Soós K, Lengyel I, Penke B, Szegedi V, Budai D (2004) Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo. NeuroRep 15:1649-1652
22. Moriguchi S, Zhao X, Marszalec W, Yeh JZ, Narahashi T (2005) Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons. J Pharmacol Exp Ther 315:125-135
23. Moriguchi S, Shioda N, Han F, Yeh JZ, Narahashi T, Fukunaga K (2009) Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation. Hippocampus 19:844-854
24. Nichols MR, Moss MA, Reed DK, Cratic-McDaniel S, Hoh JH, Rosenberry TL (2005) Amyloid-protofibrills differ from amyloid-aggregates induced in dilute hexafluoroisopropanol in stability and morphology. J Biol Chem 280:2471-2480
25. Nomura I, Kato N, Kita T, Takechi H (2005) Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons. Neurosci Lett 391:1-6
26. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW (1995) Structure-activity analyses of bamyloid peptides: contributions of the b25-35 region to aggregation and neurotoxicity. J Neurochem 64:253-265
27. Raymond CR, Ireland DR, Abraham WC (2003) NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus. Brain Res 968:263-272
28. Relkin NR (2007) Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease. Exp Rev Neurother 7:735-748
29. Rogers SL, Doody RS, Mohs RS, Friedhoff LT (1998) Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil study group. Arch Intern Med 158:1021-1031
30. 2+ and ATP. J Physiol 470:705-729
31. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051-1058
32. Solntseva EI, Bukanova JV, Marchenko E, Skrebitsky VG (2007) Donepezil is a strong antagonist of voltage-gated calcium and potassium channels in molluscan neurons. Comp Biochem Physiol C 144:319-326
33. Standridge JB (2002) Pharmacotherapeutic approaches to the treatment of Alzheimer's disease. Clin Ther 26:615-630
34. Texidó L, Martín-Satué M, Alberdi E, Solsona C, Matute C (2011) Amyloid b peptide oligomers directly activate NMDA receptors. Cell Calcium 49:184-190
35. Vorobjev VS (1991) Vibrodissociation of sliced mammalian nervous tissue. J Neurosci Methods 38:145-150
36. Vorobjev VS, Sharonova IN, Haas HL (1996) A simple perfusion system for patch-clamp studies. J Neurosci Methods 68:303-307
37. Vyklicky L (1993) Calcium-mediated modulation of N-methyl-Daspartate (NMDA) responses in cultured rat hippocampal neurons. J Physiol 470:575-600
38. Walsh DM, Selkoe DJ (2007) A beta oligomers-a decade of discovery. J Neurochem 101:1172-1184
39. Welsby PJ, Rowan MJ, Anwyl R (2009) Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus. Eur J Neurosci 29:65-75
40. Wu J, Anwyl R, Rowan MJ (1995) Beta-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. NeuroRep 6:2409-2413
41. Ye L, Qiao JT (1999) Suppressive action produced by betaamyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: it's offset by (-)huperzine A. Neurosci Lett 275:187-190
42. Yuan H, Wang WP, Feng N, Wang L, Wang XL (2011) Donepezil attenuated oxygen-glucose deprivation insult by blocking Kv2.1 potassium channels. Eur J Pharmacol 657:76-83